Amiodarone-related blue–gray skin discoloration

A 55-year-old male patient had experienced an anterior wall myocardial infarction 7 years ago. Amiodarone was initiated in order to prevent monomorphic ventricular tachycardia; since then, the patient was using amiodarone. The patient noticed gradually increasing blue–gray discoloration on the skin for 5 months, particularly on the nose, forehead, and cheeks (Fig. 1). A cardiologist, a dermatologist, and an internal medicine physician examined the patient for skin discoloration. Besides the skin discoloration, physical examination and laboratory results were normal. We noticed that the blue–gray discoloration increased under sunlight. Holter-electrocardiography was performed for 72 hours to check for cardiac arrhythmia, but no arrhythmia was observed. We stopped the use of amiodarone and optimized the dosage of metaprolol. The patient used sun protection (sunscreen creams, clothing, and hats) to decrease skin discoloration on his face.